Total Funding
1
59
Total FundingPost-IPO Equity raised
Growth Score 1 in past quarter
-24 pts
Heat Score 59 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
139604
Arix Bioscience is a global venture capital company that invests in breakthrough biotechnology companies.
- Christian Schetter: Managing DirectorPast Role: Rigontec, Chief Executive Officer
Jonathan Tobin: Managing DirectorPast Role: Imperial Innovations, Healthcare Ventures Associate
About the Company
Arix Bioscience is a global venture capital firm that invests in biotechnology firms. It works with exceptional entrepreneurs and provides the capital, expertise, and global networks required to help them turn their ideas into significant new treatments for patients. As a publicly traded company, they can bring this exciting growth phase of the
industry to a wider range of investors.